Atossa Therapeutics, Inc. (ATOS)

NASDAQ: ATOS · IEX Real-Time Price · USD
1.17
+0.05 (4.46%)
Jun 24, 2022 4:00 PM EDT - Market closed
4.46%
Market Cap 148.15M
Revenue (ttm) n/a
Net Income (ttm) -21.85M
Shares Out 126.62M
EPS (ttm) -0.17
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 17,269,704
Open 1.11
Previous Close 1.12
Day's Range 1.11 - 1.21
52-Week Range 0.84 - 8.50
Beta 1.99
Analysts Buy
Price Target 5.87 (+401.7%)
Earnings Date Aug 12, 2022

About ATOS

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-1... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Nov 8, 2012
CEO Steven Quay
Employees 6
Stock Exchange NASDAQ
Ticker Symbol ATOS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for ATOS stock is "Buy." The 12-month stock price forecast is 5.87, which is an increase of 401.71% from the latest price.

Price Target
$5.87
(401.71% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Best Tips for Buying Penny Stocks in 2022? 3 to Know

Here's what you need to know about buying penny stocks in 2022 The post Best Tips for Buying Penny Stocks in 2022? 3 to Know  appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt...

Other symbols: PHXKTRA

Atossa Therapeutics Appoints Biotech Industry Communications Veteran Charles Butler as Vice President, Investor Relat...

SEATTLE, June 02, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to develop innovative proprietary medicines in areas of significan...

Atossa Therapeutics to Present at the H.C. Wainwright Global Hybrid Investment Conference

SEATTLE, May 18, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to develop innovative proprietary medicines in areas of significant...

Atossa Therapeutics to Present at the Q2 Investor Summit Conference

SEATTLE, April 27, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet med...

Atossa Therapeutics Announces Completion of Part B of Clinical Study of AT-H201

NEBULIZED FORMULATION BEING DEVELOPED TO IMPROVE LUNG FUNCTION IN BOTH ACTIVE-DISEASE COVID-19 PATIENTS AND “LONG HAUL” PATIENTS WITH POST-INFECTION PULMONARY DISEASE

Atossa Therapeutics to Present at the Maxim Group 2022 Virtual Growth Conference

SEATTLE, March 23, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in oncology and infectious diseas...

Hot Penny Stocks to Watch Next Week? 3 For Your List

Which penny stocks are on your watchlist for next week? The post Hot Penny Stocks to Watch Next Week?

Other symbols: CLVSEOSE

Atossa Therapeutics Announces Issuance of Key U.S. Patent Covering Endoxifen

SEATTLE, March 08, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in oncology and infectious diseas...

Atossa Therapeutics Announces Year-End 2021 Financial Results and Provides Corporate Update

SEATTLE, Feb. 28, 2022 (GLOBE NEWSWIRE) --  Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in oncology and infectious diseas...

Atossa Therapeutics President and CEO Dr. Steven C. Quay Issues Annual Letter to Stockholders Highlighting Key Recent...

SEATTLE, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medi...

Atossa Therapeutics Announces Advancement to Part B of Clinical Study of AT-H201

Nebulized Formulation Being Developed to Improve Lung Function in Both Active-disease COVID-19 Patients and “Long Haul” Patients With Post-Infection Pulmonary Disease Nebulized Formulation Being Develop...

Atossa Therapeutics Begins Enrollment of Phase 2 Clinical Study of Oral Endoxifen in Sweden

SEATTLE, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medic...

Physician-Scientist Steven Quay Calls for International Effort to Investigate a Coronavirus discovered in Laos by Ins...

SEATTLE, Dec. 16, 2021 /PRNewswire/ -- Physician-Scientist Steven Quay, MD, PhD has published an e-print on his research into a new coronavirus, named BANAL-236, reported by the Institut Pasteur in Sept...

3 Penny Stocks to Watch With Bullish Sentiment Right Now

Are these penny stocks on your list of small-caps to watch right now? The post 3 Penny Stocks to Watch With Bullish Sentiment Right Now appeared first on Penny Stocks to Buy, Picks, News and Information...

Other symbols: CEIKOS

Atossa Therapeutics Completes Pre-IND Meeting with U.S. Food & Drug Administration

Input Received on Pathway for Proprietary Z-Endoxifen to Treat Breast Cancer in Neoadjuvant Setting Input Received on Pathway for Proprietary Z-Endoxifen to Treat Breast Cancer in Neoadjuvant Setting

3 Reddit Penny Stocks For Your Early December Watchlist

Check these Reddit penny stocks out for your December 2021 watchlist The post 3 Reddit Penny Stocks For Your Early December Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information |...

Other symbols: DAREMETX

Registration Is Now Open For The Tribe Public Webinar Event On November 30, 2021 “A Town Hall Q&A Event With Atossa T...

Atossa's CEO & Founder, Dr. Steven Quay, M.D., Ph.D. & Kyle Guse, GC & CFO will address a series of questions regarding Atossa's research programs and future developments Atossa's CEO & Founder, Dr. Ste...

Atossa Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update

SEATTLE, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative proprietary medicines in oncology and infect...

Atossa Therapeutics CEO Dr. Steven Quay Emphasizes Importance of Breast Cancer Screening During Breast Cancer Awarene...

Global Pandemic Caused a Significant Drop In Mammograms as Clinics Remained Closed Global Pandemic Caused a Significant Drop In Mammograms as Clinics Remained Closed

Atossa Therapeutics Begins Enrollment in Clinical Study of AT-H201 in Australia

NEBULIZED FORMULATION BEING DEVELOPED TO IMPROVE LUNG FUNCTION IN BOTH ACTIVE-DISEASE COVID-19 PATIENTS AND “LONG HAUL” PATIENTS WITH POST-INFECTION PULMONARY DISEASE NEBULIZED FORMULATION BEING DEVELOP...

Most Active Penny Stocks to Buy? Check These 4 Out Right Now

These active penny stocks could be worth adding to your list right now The post Most Active Penny Stocks to Buy? Check These 4 Out Right Now appeared first on Penny Stocks to Buy, Picks, News and Inform...

Other symbols: BLINCEISOS

Hot Penny Stocks on Reddit to Watch Right Now

Reddit penny stocks are here to stay; have you heard of these three? The post Hot Penny Stocks on Reddit to Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc...

Other symbols: GNUSSEEL

Top Penny Stocks on Reddit For Your Watchlist Right Now

If you're looking for penny stocks on Reddit, check these three out first The post Top Penny Stocks on Reddit For Your Watchlist Right Now appeared first on Penny Stocks to Buy, Picks, News and Informat...

Other symbols: JOBMILE

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fid...

New York, New York--(Newsfile Corp. - September 13, 2021) -  Levi & Korsinsky announces that it has commenced an investigation of Atossa Therapeutics, Inc. (NASDAQ: ATOS) concerning possible breaches of...

3 Hot Penny Stocks For This Week's Small-Caps Watchlist

Making a penny stocks watchlist for this coming week? Check these 3 small-caps out The post 3 Hot Penny Stocks For This Week's Small-Caps Watchlist appeared first on Penny Stocks to Buy, Picks, News and...

Other symbols: DNNPAYS